Medicare Enrolled
Dr. David Macari, M.D.
Hospitalist Physician · Sylvania, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Macari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Macari
Dr. David Macari is a hospitalist physician in Sylvania, OH, with 12 years of NPI registration. Based on federal Medicare data, Dr. Macari performed 859 Medicare services across 492 unique beneficiaries.
Between the years covered by Open Payments, Dr. Macari received a total of $6,174 from 76 pharmaceutical and/or device companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Macari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 15% volume in OH
$6,174 industry payments
Medicare Practice Summary
Medicare Utilization ↗859
Medicare services
Top 15% in OH for hospitalist physician
492
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
305 | $127 | $221 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
280 | $91 | $165 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $135 | $354 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $90 | $182 |
| New patient office visit, complex (60-74 min) | 45 | $162 | $400 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $62 | $127 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $114 | $315 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $66 | $112 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $101 | $239 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,174
Total received (2018-2024)
Avg $882/year across 7 years
Top 2% in OH for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
350
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,036 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,621
2023
$1,427
2022
$1,358
2021
$748
2020
$384
2019
$245
2018
$391
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$208
Novartis Pharmaceuticals Corporation
$188
AstraZeneca Pharmaceuticals LP
$158
PFIZER INC.
$82
Astellas Pharma US Inc
$79
Daiichi Sankyo Inc.
$61
Genentech USA, Inc.
$61
E.R. Squibb & Sons, L.L.C.
$59
Adaptive Biotechnologies Corporation
$58
Janssen Biotech, Inc.
$57
Incyte Corporation
$57
Eisai Inc.
$44
PharmaEssentia USA Corporation
$41
SOBI, INC
$40
Merck Sharp & Dohme LLC
$36
Novocure Inc.
$36
Pharmacosmos Therapeutics Inc.
$34
Aveo Pharmaceuticals, Inc.
$24
Stemline Therapeutics Inc.
$23
EMD Serono, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Tempus AI, Inc
$22
Blueprint Medicines Corporation
$22
ABBVIE INC.
$21
RECORDATI_RARE_DISEASES_INC.
$21
Alexion Pharmaceuticals, Inc.
$20
Karyopharm Therapeutics Inc.
$20
Regeneron Healthcare Solutions, Inc.
$18
GlaxoSmithKline, LLC.
$18
Genmab U.S., Inc.
$18
Exelixis Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
TerSera Therapeutics LLC
$13
Top 3 companies account for 34.2% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$575
Amgen Inc.
$424
Novartis Pharmaceuticals Corporation
$393
AstraZeneca Pharmaceuticals LP
$342
E.R. Squibb & Sons, L.L.C.
$230
Genentech USA, Inc.
$218
Janssen Biotech, Inc.
$213
Incyte Corporation
$203
Astellas Pharma US Inc
$194
PFIZER INC.
$176
GENZYME CORPORATION
$146
BeiGene USA, Inc.
$137
Adaptive Biotechnologies Corporation
$133
Kite Pharma, Inc.
$129
Agios Pharmaceuticals, Inc.
$126
Daiichi Sankyo Inc.
$122
Blueprint Medicines Corporation
$119
Seagen Inc.
$117
G1 Therapeutics, Inc.
$111
Takeda Pharmaceuticals U.S.A., Inc.
$108
Regeneron Healthcare Solutions, Inc.
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
Gilead Sciences, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$67
Eisai Inc.
$67
PharmaEssentia USA Corporation
$65
EMD Serono, Inc.
$65
JAZZ PHARMACEUTICALS INC.
$61
SOBI, INC
$61
Alexion Pharmaceuticals, Inc.
$58
Karyopharm Therapeutics Inc.
$58
Jazz Pharmaceuticals Inc.
$57
TerSera Therapeutics LLC
$48
ARRAY BIOPHARMA INC
$46
Bayer HealthCare Pharmaceuticals Inc.
$43
Genmab U.S., Inc.
$39
Mirati Therapeutics, Inc.
$39
ABBVIE INC.
$39
GlaxoSmithKline, LLC.
$38
Lilly USA, LLC
$37
SERVIER PHARMACEUTICALS LLC
$37
Aveo Pharmaceuticals, Inc.
$37
Rigel Pharmaceuticals, Inc.
$36
Merck Sharp & Dohme LLC
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
MorphoSys, US Inc.
$36
RECORDATI_RARE_DISEASES_INC.
$36
Novocure Inc.
$36
Exelixis Inc.
$35
Pharmacosmos Therapeutics Inc.
$34
EISAI INC.
$33
Foundation Medicine, Inc.
$30
Lexicon Pharmaceuticals, Inc.
$27
Stemline Therapeutics Inc.
$23
Organon LLC
$23
Tempus AI, Inc
$22
CTI BioPharma Corp.
$20
TESARO, Inc.
$20
Shield Therapeutics Inc
$19
AMAG Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$19
Sun Pharmaceutical Industries Inc.
$18
NESTLE HEALTHCARE NUTRITION INC.
$18
Puma Biotechnology, Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Pharmacyclics LLC, an AbbVie Company
$17
Dendreon Pharmaceuticals LLC
$17
Alnylam Pharmaceuticals Inc.
$16
Merck Sharp & Dohme Corporation
$15
EUSA Pharma (US) LLC
$15
PUMA BIOTECHNOLOGY, INC.
$14
Deciphera Pharmaceuticals Inc.
$14
Seattle Genetics, Inc.
$14
Clovis Oncology, Inc.
$14
Sobi, Inc
$13
ADC Therapeutics America, Inc.
$12
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · AYVAKIT · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CARVYKTI · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · GAVRETO · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · Odomzo · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XPOVIO · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for hospitalist physician in OH.
Geographic Context
Hospitalist physicians within 10 mi
27
Per 100K population
6.3
County median income
$60,095
Nearest hospital
ASSURANCE HEALTH TOLEDO LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Macari is a clinical cardiology specialist, with above-average Medicare volume (top 15% in OH), with low-engagement industry engagement in the top 2% of OH peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Macari experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Macari performed 305 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macari receive payments from pharmaceutical companies?
Yes. Dr. Macari received a total of $6,174 from 76 companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macari's costs compare to other hospitalist physicians in Sylvania?
Dr. Macari's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Sylvania
Browse hospitalist physicians in Sylvania ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in OH
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in OH
Which OH hospitalist physicians receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology